LAW-based CARB-X Awards $24 Million for Superbug Antibiotics
Wellcome Trust gives $155M for nonprofit’s work on “huge global challenge” Kevin Outterson, LAW’s N. Neal Pike Scholar in Health and Disability Law, leads CARB-X, the world’s largest public-private partnership working to accelerate development of urgently needed new antimicrobials. Photo by Jackie Ricciardi. A BU School of Law–based public-private partnership to spur the development of […]
New Tool to Diagnose Zika
BU researcher on team that created prototype for simple new test Dana Braff (ENG’17), one of the lead authors on a Cell paper that describes a prototype for a new Zika diagnostic (photo above). Zika grabbed the world’s attention in late 2015, when scientists in Brazil began to suspect a connection between the virus and […]
Zika: The Next Pandemic
SPH professor concerned about virus, but also “prepared to be alarmed” The Aedes aegypti mosquito, which spreads dengue, chikungunya, and zika. On February 1, 2016, Margaret Chan, director-general of the World Health Organization (WHO), declared Zika virus “a public health emergency of international concern.” Chan’s statement said the 2016 outbreak is an “extraordinary event” and […]
Preventing an Antibiotic Apocalypse
The business model for drug innovation is broken — universities key to figuring out fixes, says health law prof By: Sara Rimer Kevin Outterson is a leading scholar on the economic and legal global framework needed to combat resistance and keep antibiotics available for future generations. Photo by Jackie Ricciardi. When Kevin Outterson, a professor […]